3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt
3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt(93940-53-5)
- Name: 3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt
- Synonyms:Benzoicacid, 2-hydroxy-3-[(4-nitrophenyl)azo]-5-[(5-sulfo-1-naphthalenyl)azo]-, sodiumsalt (9CI)
- Molecular Formula:C23H15 N5 O8 S . x Na
- Molecular Weight:565.42256
- CAS Registry Number:93940-53-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.93940-53-5 3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.93940-53-5 3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.93940-53-5 3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]

Other Product
- 34848-24-3/4,4,4-trifluoro-1-(4-nitrophenyl)-3-(trifluoromethyl)butane-1,3-diol
- 83935-64-2/4'-ISOCYANATO-5'-NITROBENZO-15-CROWN-5,99.5%
- 5426-97-1/1-(diaminomethylidene)-2-naphthalen-2-ylguanidine
- 75659-69-7/5-Acetamido-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonic acid,bis(diethanolamine)salt
- 68037-23-0/1,4-Butanediol, 2,3-bis((gamma-omega-perfluoro-C6-20-alkyl)thio) derivs, polymers with 1,6-diisocyanatotrimethylhexane and 2,2-(methylimino)bis(ethanol)
- 41992-05-6/2,8,8-trimethyl-2-[3-(trimethylammonio)propyl]-2-azonia-8-silaspiro[4.5]decane
- 7061-69-0/N-[2-(4-tert-butylphenoxy)ethyl]-2-methyl-N-(2-methylpropyl)propan-1-amine
- 128487-69-4/S-[(2Z)-2-amino-2-{[1-(3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl)ethyl]imino}ethyl] hydrogen thiosulfate
- 86910-90-9/S-(5-{[(4-methylphenyl)carbamothioyl]amino}-1,3,4-thiadiazol-2-yl) butanethioate
- 56211-51-9/4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-7-(b-D-glucofuranosyloxy)-5-hydroxy-
- 106000-49-1/5H,16H-Benzo[e]benzo[3',4'][1]benzazepino[7',8':8,9][1,4,7,10,13,16]benzohexaoxacyclooctadecino[18,19-b]azepine-5,17,22,32(6H)-tetrone,9,10,12,13,25,26,28,29-octahydro-
- 2350-99-4/P-TOLYLAMINO-ACETIC ACID HYDRAZIDE
- 63017-86-7/4-bromo-1-methyl-2-nitronaphthalene
- 23544-52-7/2-Pyrrolidinone,5-hydroxy-1-[2-[3-(1-methyl-1H-imidazol-5-yl)-3-oxopropyl]phenyl]- (9CI)
- 6939-51-1/2-amino-6-[(3-chloro-4-methylphenyl)amino]-5-nitrosopyrimidin-4(1H)-one
- 85187-86-6/2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium methyl sulphate
- 93763-23-6/Fatty acids, rape-oil, reaction products with 2-((2-aminoethyl)amino)ethanol
- 5277-56-5/2-chloro-N-[(E)-(4-chloro-3-nitrophenyl)methylidene]aniline
- 1453-93-6/Protopanaxatriol
- 93940-53-5/3-[(4-nitrophenyl)azo]-5-[(5-sulpho-1-naphthyl)azo]salicylic acid, sodium salt
- 32537-41-0/1,2-Ethanediamine,N1-(4-azatricyclo[4.3.1.13,8]undec-4-en-5-yl)-N2-phenyl-, hydrochloride (1:1)
- 62851-59-6/Eurotin A (9CI)
- 4412-92-4/1,3-Benzodioxole-5-methanol,a-3-furanyl-
- 74494-65-8/7H-Furo[3',2':4,5]furo[2,3-c]xanthen-7-one,1,2,3a,12c-tetrahydro-8-hydroxy-6,10,11-trimethoxy-, (3aR-cis)- (9CI)
- 204244-39-3/L-Tryptophanamide,L-alanyl-L-tyrosylglycyl-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-(9CI)
- 17608-09-2/2-METHOXYBENZYL ISOTHIOCYANATE
- 111461-47-3/Neuropeptide C(Cardisoma carnifex sinus gland) (9CI)
- 136881-43-1/7H-Pyrido[4,3-c]carbazole-6-carboxamide,N,N'-([4,4'-bipiperidine]-1,1'-diyldi-2,1-ethanediyl)bis[10-methoxy- (9CI)
- 31077-20-0/methyl 6-chloro-4,6-dideoxyhexopyranoside
- 21861-22-3/AKOS BBS-00001299